Delivery Order HT940823D0002-HT940825F0003
- Not listed
- This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
- This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
- This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products such as blood testing equipment, reagents, and consumables. The contract, valued at $193,054.06, is for annual drop-shipment of reagents under the agency's General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The contract does not have a set-aside designation. Immucor is a key supplier of...
- The Department of the Air Force Air Education and Training Command awarded a firm-fixed price delivery order contract worth $122,698.05 to Immucor Inc., a for-profit manufacturer of goods, for the provision of blood typing reagents. Immucor has extensive experience providing specialized reagents, blood analyzers, testing equipment, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood banking operations for federal health networks and...
- This is a delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit organization and manufacturer of in vitro diagnostic reagents, test kits, and blood banking supplies. The $145,046.75 contract is for the provision of blood bank reagents and is issued under Immucor's General Services Administration (GSA) Multiple Award Schedule contract for in vitro diagnostics, reagents, and tests. The award does not utilize a set-aside designation. Immucor has a history of...
- This is a federal contract award by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The $73,426.14 firm fixed-price contract is for the supply and delivery of reagents. This contract is not set aside and is a delivery order issued under Immucor's existing General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and...
- This federal contract award, N6809622P0004, was issued by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. The $80,569.98 firm fixed-price purchase order is for the delivery of IMMUCOR REAGENTS and REAGENT SUPPLIES. This contract is not set aside for any specific business category. Immucor Inc. is a long-standing federal contractor, providing critical...
- This contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, is for the delivery of blood reagents, test kits, and diagnostic products to support the testing programs and healthcare services of the Defense Health Agency (DHA). The $260,536.03 firm fixed-price delivery order was issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. The award does not have a...
- HT940823D0002Indefinite Delivery Contract
- HT940823D0002-HT940825F0003Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of automated blood testing equipment, reagents, and consumables. The contract, valued at $54,457.50, is for the provision of blood typing equipment and reagents. The contract does not have a set-aside designation. Immucor Inc. is a key supplier of specialized blood banking technologies and supplies that support medical testing and healthcare operations across federal networks, including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. The company holds several significant Indefinite Delivery/Blanket Purchase Agreement (IDV/BPA) contracts with these agencies for the recurring purchase of critical medical supplies such as blood bank reagents and in vitro diagnostic reagents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/1/25 | |
| Not listed | Not listed | $54.5k | 3/11/25 |